# Lactoferrin in Covid-19 Hospitalized Patients

> **NCT04847791** · NA · UNKNOWN · sponsor: **Paolo Manzoni** · enrollment: 194 (estimated)

## Conditions studied

- Covid19

## Interventions

- **DIETARY_SUPPLEMENT:** Bovine lactoferrin
- **DIETARY_SUPPLEMENT:** Placebo administration

## Key facts

- **NCT ID:** NCT04847791
- **Lead sponsor:** Paolo Manzoni
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-01-14
- **Primary completion:** 2022-01-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 194 (ESTIMATED)
- **Last updated:** 2021-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04847791

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04847791, "Lactoferrin in Covid-19 Hospitalized Patients". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT04847791. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*